Top Markets
#1 Islamic Coin Islamic Coin +151.49%
#2 DOVU DOVU +48.06%
#3 Akedo Akedo +42.30%
#4 Velvet Velvet +37.91%
#5 Black Phoenix Black Phoenix +34.36%
#6 Cross Cross +17.98%
#7 DoubleZero DoubleZero +17.92%
#8 Cap Cap +14.84%
#9 Tutorial Tutorial +10.61%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.25%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Fabino Enterprises Ltd Fabino Enterprises Ltd

Fabino Enterprises Ltd

FABINO
Classifica tra le azioni #39501
Operating from its Sonipat, India base since its incorporation in 2011, Fabino... Operating from its Sonipat, India base since its incorporation in 2011, Fabino Enterprises Limited is engaged in the manufacturing, marketing, trading, and packaging of pharmaceutical and wellness-oriented consumer products throughout India. Its extensive product portfolio, marketed under the Fabino and Keepshine brands, includes allopathic and select herbal medications—such as tablets, ointments, and syrups—along with various food and general wellness items. The company also extends its reach globally by exporting wellness and Fast-Moving Consumer Goods (FMCG) like coffee, malt powder, protein powder, and hair shampoo. Fabino's products are distributed and promoted via its own robust internal network and specialized sales force. Notably, the entity adopted its current name, Fabino Enterprises Limited, in June 2024, having previously been known as Fabino Life Sciences Limited.
Prezzo delle azioni
$0.22413867
Ultima sincronizzazione: 2026-05-25
Capitalizzazione di mercato
$463.14K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-24.40%
Paese
IN
Scambia Fabino Enterprises Ltd (FABINO)

Categoria

Healthcare
Rapporto P/B per Fabino Enterprises Ltd (FABINO)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Fabino Enterprises Ltd, il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Fabino Enterprises Ltd da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.6634 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0941 -
US